Literature DB >> 11160185

Natural autoreactive B cells in transgenic mice reproduce an apparent paradox to the clonal tolerance theory.

S Koenig-Marrony1, P Soulas, S Julien, A M Knapp, J C Garaud, T Martin, J L Pasquali.   

Abstract

Naturally occurring autoreactive B cells are thought to be physically eliminated or rendered functionally silent through different mechanisms of tolerance. However, multireactive low affinity natural autoantibody-producing B cells seem to escape these mechanisms in normal adults and could constitute the B cell pool from which pathological autoantibodies can emerge. To analyze this apparent paradox to the clonal tolerance theory, we have made two transgenic mouse lines (mu(k), mudelta(k)) producing a natural low affinity multireactive human autoantibody. These models enable us to test both the central tolerance mechanisms (reactivity with single-stranded DNA) and the peripheral tolerance mechanisms after Ag administration. Not only are the multireactive B cells not deleted in the bone marrow, they circulate and remain in the periphery even after the prolonged administration of Ag, the presence of membrane IgD increasing the number of mature autoreactive B cells. Self-reactive B cells are shown to be autoantigen ignorant both in vivo and in vitro, but they are not anergic because they can be easily activated through both B cell receptor-dependent and -independent pathways. Thus, these mouse lines reproduce an apparent paradox to the clonal tolerance theory meriting further investigation of the biological significance of this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160185     DOI: 10.4049/jimmunol.166.3.1463

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  The riddle of the dual expression of IgM and IgD.

Authors:  Roland Geisberger; Marinus Lamers; Gernot Achatz
Journal:  Immunology       Date:  2006-08       Impact factor: 7.397

2.  The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases.

Authors:  Lee Ann Garrett-Sinha; Alyssa Kearly; Anne B Satterthwaite
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

3.  Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection.

Authors:  Pauline Soulas; Anne Woods; Benoit Jaulhac; Anne-Marie Knapp; Jean-Louis Pasquali; Thierry Martin; Anne-Sophie Korganow
Journal:  J Clin Invest       Date:  2005-07-21       Impact factor: 14.808

Review 4.  Innate pathways to B-cell activation and tolerance.

Authors:  Steve P Crampton; Elisaveta Voynova; Silvia Bolland
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

5.  Requirement for Transcription Factor Ets1 in B Cell Tolerance to Self-Antigens.

Authors:  Lisa Russell; Shinu John; Jaime Cullen; Wei Luo; Mark J Shlomchik; Lee Ann Garrett-Sinha
Journal:  J Immunol       Date:  2015-09-09       Impact factor: 5.422

Review 6.  B cells and immunological tolerance.

Authors:  Nataly Manjarrez-Orduño; Tâm D Quách; Iñaki Sanz
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

7.  The regulation of autoreactive B cells during innate immune responses.

Authors:  Barbara J Vilen; Jennifer A Rutan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

8.  Influenza virus-induced type I interferon leads to polyclonal B-cell activation but does not break down B-cell tolerance.

Authors:  Anne Woods; Fanny Monneaux; Pauline Soulas-Sprauel; Sylviane Muller; Thierry Martin; Anne-Sophie Korganow; Jean-Louis Pasquali
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

9.  MyD88 negatively controls hypergammaglobulinemia with autoantibody production during bacterial infection.

Authors:  Anne Woods; Pauline Soulas-Sprauel; Benoit Jaulhac; Bérénice Arditi; Anne-Marie Knapp; Jean-Louis Pasquali; Anne-Sophie Korganow; Thierry Martin
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

10.  Carabin deficiency in B cells increases BCR-TLR9 costimulation-induced autoimmunity.

Authors:  Jean-Nicolas Schickel; Jean-Louis Pasquali; Anne Soley; Anne-Marie Knapp; Marion Decossas; Aurélie Kern; Jean-Daniel Fauny; Luc Marcellin; Anne-Sophie Korganow; Thierry Martin; Pauline Soulas-Sprauel
Journal:  EMBO Mol Med       Date:  2012-10-29       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.